| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jun―16 |
Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection |
Dorottya Szabó, Pál Tod, Fruzsina Maácz, Flóra Gölöncsér, Bernadett Iring-Varga, Bibiána Török, et al. (+4) Gyula Zsidei, Bernadett Pályi, Zoltán Kis, Beáta Sperlágh |
| 2 |
[GO] |
2024―Sep―07 |
Oxytocin Modulation of Explicit Pandemic Stigma in Men with Varying Social Anxiety Levels |
Yuwei Wang, Jiajia Zhu, Jiaxi Wang, Yan Mu |
| 3 |
[GO] |
2022―Mar―04 |
Inflammation at the crossroads of COVID-19, cognitive deficits and depression |
Natalia M. Lyra e Silva, Fernanda G.Q. Barros-Aragão, Fernanda G. De Felice, Sergio T. Ferreira |
| 4 |
[GO] |
2021―Oct―18 |
SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants |
Claudia P. Figueiredo, Fabrícia L. Fontes-Dantas, Andrea T. da Poian, Julia R. Clarke |
| 5 |
[GO] |
2021―Aug―26 |
Covid-19 interface with drug misuse and substance use disorders |
I.E. Cisneros, K.A. Cunningham |
|
